Biotech Events And Company Events
2013 Conference in Applied Bioinformatics & Public Health Microbiology
When May 15, 2013 to May 17, 2013 Where Moller Centre, Churchill College, Cambridge, UK Introduction Till now, the conference registration and abstract submission has closed. But the conference indeed accepts waitlist. Organized by Wellcome Trust, the conference aims to recent
The 2013 Bio Therapeutics Conference
2013 Euroscicon BioTherapeutics Week When May 14 to May 17, 2013 Where The Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage, UK Introduction Organized by Euroscicon, the event consists of four channels which all focus on the research, development and standardization involved
The New Lawsuit on Pfizer with Previous Blows Back
According to the Reuters report, on Apr 3, 2013, Wed, an appellate judge panel in Boston held the ruling on Pfizer Inc., which is the largest US drugmaker. In the ruling, Kaiser Foundation Health Plan was supported for its appeal to Pfizer that it suffered. Pfizer was asked to pay about $142
Worldwide Biotech/Biopharma Alliance (Apr. 1, 2013～Mar. 26, 2013)
On Apr. 1, 2013, Swiss specialty chemicals and life sciences group Lonza did the review evaluation on whether continue to invest in its joint venture with Teva in "biosimilar" drugs, its Chief Executive said. The expiry of patents on expensive biotech medicines to treat cancer and
Another Forward Step of Laboratory Standardization in Diagnostic Procedure
In medical transplant cases, finding allogeneic stem cells are one challenge, according to the statistics, there are about 50,000 people a year urgently require a stem cell transplant; while another challenge is the precision and speed of detecting the difference between donors and recipient
The 9th European Antibody Congress
When Nov. 11 to Nov. 13, 2013 Where Starling Geneva Hotel &Conference Center, Geneva, Switzerland Introduction Organized by Terrapinn, the tree days’ event brings the monoclonal antibody (mAb) and next generation technology industry together. The conference will focus on mAb
The 2013 Life Sciences Prize
Some entrepreneurs, including Facebook's Mark Zuckerberg and Google's Sergey Brin launched a prize to encourage contributors who devote to the advancement of incentivizing others to pursue research, but not fund research. In this Feb., 11 scientists have each won £2 million as part of a
2013 Sample Prep and Target Enrichment in Molecular Diagnostics Conference
When 10 Apr, 2013 to 11 Apr, 2013 Where Boston, MA, United States Introduction Sample preparation is important for research. Pre-detection processing is a pivotal part of molecular diagnostics. Its modernization should closely follow or even precede the emergence of new diagnostic
Membrane Protein Structure and Function Conference
When May 13, 2013, till May 17, 2013 Where Suzhou Dushu Lake Conference Center, Suzhou, China Introduction The Cold Spring Harbor Asia Membrane Protein Structure and Function conference is organized by institutions such as University of Freiburg, Stanford University, University of Virginia,
Sample Preparation on the Detection and Identification of Virus, Toxin and Pathogen
sample Prep 2013 Conference When May 9 to May 10, 2013 Where San Diego Hilton & Resort, San Diego, CA, USA Introduction Sample prep 2013 Conference on the detection and identification of virus, toxin and pathogen belongs to the 7th meeting in the Knowledge Foundation’s Sample
XI Discussions in Structural Molecular Biology
When March, 14 – March 16, 2013 Where Ubytování, wellness hotel Rezidence Nové Hrady, in the Academic conference center "Nový zámek" Introduction Structural biology is a branch of molecular biology, biochemistry, and biophysics concerned
14th Annual G Protein-Coupled Receptor (GPCR) Retreat Conference
When Oct. 17th to 19th, 2013 Where 1260 Euclid Avenue, Cleveland, Ohio 44115, United States Introduction The GPCR Retreat is an annual joint meeting that rotates around locations in the United States and Canada surrounding the Great Lakes region (Ontario, Quebec, Michigan, New York, and Ohio).
2013 BioNetwork East
When April 3th to April 5th, 2013 Where Eden Roc Renaissance, 4525 Collins Avenue, Miami Beach, Florida 33140 Introduction Since 2003 BioNetwork has been providing the essential platform for business development executives across the pharmaceutical and biotechnology space to efficiently come
The Worldwide Biotech’s Approval or Restricting by FDA (From Feb. 15 to Feb. 22)
On Feb 22, 2013, Roche's ($RHHBY) Genentech picked up FDA approval for its late-stage breast cancer therapy Kadcyla, formerly T-DM1, which uses antibodies to deliver cancer drugs directly to the offending cells. The treatment combines ImmunoGen's ($IMGN) taxane chemotherapy drug, DM1, with an
The 2nd Annual Cell Line Development and Engineering in Asia
When March 4th, 2013, to March 6th, 2013 Where Grand Hvatt Shanghai, China Introduction This conference is organized by IBC Asia (s) Pte Ltd and be held alongside the 3rd Annual Advanced Biomanufacturing and Single Use Systems Asia. This is the second secession of this serial meeting. 2nd
MorphoSys AG Collaborates with Heptares Therapeutics on GPCRs
On Feb., MorphoSys AG and the UK-based Heptares Therapeutics signed alliance to discover and develop novel antibody therapeutics targeting G protein-coupled receptors (GPCRs), cataloged in membrane proteins that involve in a broad range of biological processes and diseases. Currently GPCRs
The Third Session of Drug Development Boot Camp
For Biotech and Pharma Company Executives When November 20–21, 2013 Where Harvard Club, Boston, Massachusetts Introduction With the trend of more complex and fierce drug development market, knowing the corresponding process and being able to navigate it with great skills will become
Worldwide Blockbusters’ Movements during Feb., 2013
GlaxoSmithKline (GSK) has joined up with investigators at Vanderbilt University to quick march their preclinical work on a new obesity drug into clinical studies. The pharma giant has been warming up to Roger Cone and his Vanderbilt team. With significant backing from the NIH, they have identified
2013 Asia Biotech Invest Conference
When 3rd June 2013 at 09:00 - 5th June 2013 at 17:00 Where Sheraton Hotel & Towers, 20 Nathan Road, Kowloon, Hong Kong Introduction Organized by AusBiotech and Beacon Events, the conference is held in the financial hub Hong Kong. As the name suggests, the conference will bring
GTC 2013, Stem Cell Commercialization & Partnering conference
Introduction GTC's Stem Cell Commercialization & Partnering conference, part of the 10th Stem Cell Summit, will be held on in Boston. This conference will present information regarding cutting-edge developments in all areas of stem cell research including Stem Cell, Induced Pluripotent Stem
Worldwide Biotech/Biopharma Alliance (Feb. 4, 2013～Jan. 29. 2013)
On Feb. 4, 2013, Karolinska Development AB (publ) entered into an agreement with Mayo Clinic with the aim of identifying commercialization opportunities in Mayo’s life science innovations that will improve patient care. Through this agreement, Karolinska Development will evaluate innovations
The 2013 BIA Lifetime Achievement Award Goes to Andy Richards
On Feb. 1st, 2013 during the annual Gala Dinner, the BioIndustry Association (BIA) announced its lifetime achievement award winner—Andy Richards. When presented Andy with the award, the BIA chairman, Tim Edwards gave his comments and praise on the winner, said he is a true leader in
The FDA Approval of Flublok
On Jan. 16, 2013, the U.S. Food and Drug Administration (FDA) announced the approval of Flublok for the prevention of seasonal influenza in people aged from 18 to 49. Flublok is the first trivalent influenza vaccine that uses baculovirus expression system and novel recombinant DNA technology.
2013, the 2nd Biotechnology World Congress
When From 18th to 21st February, 2013 for four days Where Dubai Women's College, Dubai, United Arab Emirates Introduction Organized by Eureka Science with the support of the Higher Colleges of Technology, UAE, the conference focuses on the interdisciplinary fields of biotechnology.
The Cooperation between BaroFold and Lonza for PreEMT Protein Refolding Technology
On Jan. 16, 2013, Lonza, a biological development company, and BaroFold, Inc., an innovative protein technology developer, announced a non-exclusive technology and license agreement. The technology will offer them a comprehensive toolbox for microbial recombinant protein production In line
